Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Knapp

Showing results (241-250 of 451) with videos related to

Pageof 46
Sort By:
Scandinavian Journal of Caring Sciences|April 23, 2010
Effects of the implementation of the web-based patient support system on staff's attitudes towards computers and IT use: a randomised controlled trialMarita Koivunen, Maritta Välimäki, Anita Patel, et al.
Plos One|October 9, 2015
Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled TrialCatherine Henderson, Martin Knapp, Ksenija Yeeles, et al.
The Lancet. Healthy Longevity|September 12, 2022
Effective interventions for potentially modifiable risk factors for late-onset dementia: a costs and cost-effectiveness modelling studyNaaheed Mukadam, Robert Anderson, Martin Knapp, et al.
Pharmacoeconomics|March 29, 2008
Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO studyMartin Knapp, Frank Windmeijer, Jacqueline Brown, et al.
Age and Ageing|December 7, 2019
Projections of care for older people with dementia in England: 2015 to 2040Raphael Wittenberg, Bo Hu, Carol Jagger, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 2, 2014
Experiences of front-line health professionals in the delivery of telehealth: a qualitative studyVirginia MacNeill, Caroline Sanders, Ray Fitzpatrick, et al.
Neuropsychiatric Disease and Treatment|September 2, 2017
Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM studyDelphine Saragoussi, Maëlys Touya, Josep Maria Haro, et al.
BMC Psychiatry|September 30, 2009
Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT)Stefan Priebe, Alexandra Burton, Deborah Ashby, et al.
Trials|September 16, 2011
Peer support for family carers of people with dementia, alone or in combination with group reminiscence in a factorial design: study protocol for a randomised controlled trialGeorgina Charlesworth, Karen Burnell, Jennifer Beecham, et al.
Cost Effectiveness and Resource Allocation : C/E|May 28, 2013
Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countriesAnita Patel, Paul McCrone, Morven Leese, et al.
Pageof 46

Showing results (241-250 of 451) with videos related to

Sort By:
Pageof 46
Scandinavian Journal of Caring Sciences|April 23, 2010
Effects of the implementation of the web-based patient support system on staff's attitudes towards computers and IT use: a randomised controlled trialMarita Koivunen, Maritta Välimäki, Anita Patel, et al.
Plos One|October 9, 2015
Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled TrialCatherine Henderson, Martin Knapp, Ksenija Yeeles, et al.
The Lancet. Healthy Longevity|September 12, 2022
Effective interventions for potentially modifiable risk factors for late-onset dementia: a costs and cost-effectiveness modelling studyNaaheed Mukadam, Robert Anderson, Martin Knapp, et al.
Pharmacoeconomics|March 29, 2008
Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO studyMartin Knapp, Frank Windmeijer, Jacqueline Brown, et al.
Age and Ageing|December 7, 2019
Projections of care for older people with dementia in England: 2015 to 2040Raphael Wittenberg, Bo Hu, Carol Jagger, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 2, 2014
Experiences of front-line health professionals in the delivery of telehealth: a qualitative studyVirginia MacNeill, Caroline Sanders, Ray Fitzpatrick, et al.
Neuropsychiatric Disease and Treatment|September 2, 2017
Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM studyDelphine Saragoussi, Maëlys Touya, Josep Maria Haro, et al.
BMC Psychiatry|September 30, 2009
Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT)Stefan Priebe, Alexandra Burton, Deborah Ashby, et al.
Trials|September 16, 2011
Peer support for family carers of people with dementia, alone or in combination with group reminiscence in a factorial design: study protocol for a randomised controlled trialGeorgina Charlesworth, Karen Burnell, Jennifer Beecham, et al.
Cost Effectiveness and Resource Allocation : C/E|May 28, 2013
Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countriesAnita Patel, Paul McCrone, Morven Leese, et al.
Pageof 46